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Streptococcus pneumoniae is a leading cause of pneumonia and
invasive disease, particularly, in the elderly. S. pneumoniae lung
infection of aged mice is associated with high bacterial burdens
and detrimental inflammatory responses. Macrophages can clear
microorganisms and modulate inflammation through two distinct
lysosomal trafficking pathways that involve 1A/1B-light chain 3
(LC3)-marked organelles, canonical autophagy, and LC3-associated
phagocytosis (LAP). The S. pneumoniae pore-forming toxin pneumolysin (PLY) triggers an autophagic response in nonphagocytic
cells, but the role of LAP in macrophage defense against S. pneumoniae or in age-related susceptibility to infection is unexplored. We
found that infection of murine bone-marrow-derived macrophages
(BMDMs) by PLY-producing S. pneumoniae triggered Atg5- and
Atg7-dependent recruitment of LC3 to S. pneumoniae-containing
vesicles. The association of LC3 with S. pneumoniae-containing
phagosomes required components specific for LAP, such as Rubicon
and the NADPH oxidase, but not factors, such as Ulk1, FIP200, or
Atg14, required specifically for canonical autophagy. In addition, S.
pneumoniae was sequestered within single-membrane compartments indicative of LAP. Importantly, compared to BMDMs from
young (2-mo-old) mice, BMDMs from aged (20- to 22-mo-old) mice
infected with S. pneumoniae were not only deficient in LAP and
bacterial killing, but also produced higher levels of proinflammatory
cytokines. Inhibition of LAP enhanced S. pneumoniae survival and
cytokine responses in BMDMs from young but not aged mice. Thus,
LAP is an important innate immune defense employed by BMDMs
to control S. pneumoniae infection and concomitant inflammation,
one that diminishes with age and may contribute to age-related
susceptibility to this important pathogen.
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(9–12), lead to diminished pneumococcal clearance and increased
risk of invasive pneumococcal disease in both mouse models and
humans. Phagocytic activity in alveolar macrophages is important
during early responses to subclinical infections (13–15), and during
moderate S. pneumoniae lung infection, newly generated monocytes
eggress from the bone marrow and migrate into the lungs, differentiating into monocyte-derived alveolar macrophages (16). In addition to directly eliminating the invading microbe, macrophages
secrete key cytokines, such as tumor necrosis factor (TNF),
interleukin-1β (IL-1β), and interleukin-6 (IL-6), that regulate effector cell functions and pulmonary inflammation (17–19).
Although an innate immune response is critical for pathogen
clearance, poorly controlled inflammation can lead to tissue damage and mortality (20, 21). For example, in murine models, neutrophilic infiltration can enhance pulmonary damage and disrupt
epithelial barrier function, leading to bacteremia and mortality
(22–25). Macrophages are critical not only in regulating the early
inflammatory response, but are also crucial for curtailing inflammation during the resolution phase of infection to limit tissue
damage and promote healing (26, 27).
Significance
The elderly exhibit susceptibility to many infectious agents,
including S. pneumoniae. A robust acute inflammatory response to
S. pneumoniae is associated with severe disease. S. pneumoniae
triggers canonical autophagy in nonprofessional phagocytes, but
its role in macrophages is largely unexplored. We found that
BMDMs utilize LAP, rather than canonical autophagy, to both
eliminate S. pneumoniae and modulate inflammation. Notably,
compared to young BMDMs, aged BMDMs were deficient in LAP,
resulting in compromised bacterial killing and enhanced proinflammatory responses. Thus, S. pneumoniae triggers LAP in
BMDMs, a process that controls both microbial numbers and
tissue-damaging inflammation. Importantly, LAP diminishes with
age and may contribute to the observed susceptibility of the elderly to many infectious diseases.
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treptococcus pneumoniae (pneumococcus) commonly colonizes the nasopharynx asymptomatically but is also capable of
infecting the lower respiratory tract to cause pneumonia and
spreading to the bloodstream to cause septicemia and meningitis
(1). Susceptibility to pneumonia and invasive disease caused by S.
pneumoniae is remarkably higher in individuals aged 65 and over,
leading to high rates of mortality and morbidity in the elderly
population (1, 2). In countries, such as the United States and Japan, deaths due to pneumococcal pneumonia have been on the rise
in parallel with the rapid growth in the elderly population (3, 4).
A hallmark of pneumococcal pneumonia is a rapid and exuberant
response by immune cells, such as neutrophils and macrophages.
This innate immune response to S. pneumoniae lung infection is
critical for pathogen clearance and the control of disease (5–7).
Deficiencies in the number or function of innate phagocytic cells,
such as neutropenia (8) or macrophage phagocytic receptor defects
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Elderly individuals have higher baseline and induced levels of
inflammation, a phenomenon termed inflammaging (28), that
contributes to many age-associated pathological conditions, including increased susceptibility to a variety of infectious diseases,
such as S. pneumoniae infection (7, 28–30). S. pneumoniae-induced
inflammation, characterized by increased levels of chemokines,
proinflammatory cytokines, and decreased anti-inflammatory cytokines, such as IL-10, is enhanced in the elderly (29, 31) as well as
in aged mice (32, 33) and correlates with ineffective immune responses. Age-related chronic exposure to TNF-α, for instance,
dampens macrophage-mediated S. pneumoniae clearance during
lung infection (34), and NLR family pyrin domain containing 3
inflammasome activation in macrophages diminishes upon aging in
mice (35). However, the age-related changes in macrophage effector functions leading to diminished clearance of S. pneumoniae
are incompletely understood.
One important means of macrophage-mediated pathogen
clearance is1A/1B-light chain-3 (LC3)-associated phagocytosis
(LAP), a process by which cells target phagocytosed extracellular
particles for efficient degradation (36–38). LAP combines the molecular machineries of phagocytosis and autophagy, resulting in the
conjugation of the autophagic marker, the microtubule-associated
protein LC3, to phosphatidylethanolamine on the phagosomal
membrane, generating so-called “LAPosomes” that undergo facilitated fusion with lysosomes (38, 39). Canonical autophagy targets
cytoplasmic components, such as damaged subcellular organelles
and intracellular microbes for sequestration into double-membrane
autophagic vesicles (40, 41). In contrast, LAPosomes retain the
single-membrane nature of phagosomes, and their formation requires overlapping but nonidentical genes compared to canonical
autophagy (42). In addition to enabling efficient degradation of
phagocytosed bacteria, LAP also plays important immune regulatory
roles, such as in curtailing proinflammatory cytokine production
during the subsequent innate immune response (39, 43). Indeed, the
LAP-mediated microbial defense and immunomodulatory functions
work together to limit tissue damage and restore homeostasis (38).
S. pneumoniae triggers canonical autophagy in epithelial cells
and fibroblasts, and bacteria can be found in double-membrane
vacuoles whose formation is dependent on autophagic machinery
(44). Many bacterial pathogens that induce autophagy produce
pore-forming toxins, which can damage endosomal membranes,
thus, recruiting autophagic machinery to engulf injured organelles (45). Pneumococcus-induced autophagy is dependent on
the cholesterol-dependent pore-forming toxin pneumolysin
(PLY), which triggers the autophagic delivery of S. pneumoniae
to lysosomes and results in bacterial killing (44, 46). Recently, a
kinetic examination of S. pneumoniae-targeting autophagy in fibroblasts demonstrated that canonical autophagy was preceded
by early and rapid PLY-dependent LAP (47). However, the requirements for this process were somewhat different from LAP
in macrophages, and the pneumococcus-containing LAPosomes
did not promote bacterial clearance but required subsequent transition to canonical autophagy to reduce bacterial numbers (46, 47).
In the current study, we found that S. pneumoniae infection of
murine bone-marrow-derived macrophages (BMDMs) induces
LAP in a PLY-dependent manners and that age-related defects
in BMDM LAP contributed to diminished bactericidal activity
and enhanced proinflammatory cytokine production. Our results
suggest that PLY-induced LAP promotes bacterial clearance,
and age-associated dysregulation of this process may contribute
to enhanced bacterial survival, poorly regulated inflammation,
and increased susceptibility to invasive pneumococcal disease.
Results
S. pneumoniae Triggers PLY-Dependent Lipidation of LC3, Which Is
Recruited to Internalized Bacteria. To determine if the autopha-

gic process identified in nonimmune cells also occurs in macrophages, we infected murine BMDMs with S. pneumoniae. We
33562 | www.pnas.org/cgi/doi/10.1073/pnas.2015368117

found that infection of BMDM rapidly induced conversion of
LC3-I to its vesicle-bound form LC3-II, indicating onset of
autophagy or an autophagy-related process (Fig. 1A). To identify
if specific bacterial components of S. pneumoniae, such as the
cholesterol-dependent pore-forming cytolysin PLY, were required to trigger LC3 lipidation, we infected BMDMs with several S.
pneumoniae mutants, including strains lacking pneumococcal surface protein A (ΔpspA), pneumococcal surface protein C (ΔpspC),
capsule (Δcps), or PLY (Δply). We found that the PLY-deficient
strain failed to trigger LC3-I conversion to LC3-II (Fig. 1A).
To examine PLY-mediated autophagic processes in an experimental model that permits gene silencing approaches, we
utilized murine RAW264.7 macrophages (48). As predicted, serum starvation, a documented inducer of autophagy (49), resulted
in production of LC3-II (Fig. 1B). S. pneumoniae infection also
triggered LC3-II production in these macrophages in a manner
dependent on the multiplicity of infection (MOI) (Fig. 1B).
Fluorescent microscopic examination of S. pneumoniae-infected
cells that stably express a green fluorescent protein (GFP)-tagged LC3 protein (GFP-LC3) revealed that LC3 colocalized with
∼35% of intracellular S. pneumoniae within the first 0.5 h with
colocalization gradually diminishing after 1 h (Fig. 1 C and D).
PLY-deficient mutants of S. pneumoniae strains TIGR4 or D39
were significantly diminished for LC3 colocalization compared to
wild-type (WT), and marker rescue of S. pneumoniae strain
D39Δply reversed this defect (Fig. 1E). The endopeptidase PepO
has been implicated in stimulation of peritoneal derived macrophage autophagy by S. pneumoniae strain D39 (50), but the inability of a PLY-deficient strain D39 to trigger LC3 colocalization
indicates that PepO is insufficient to initiate the autophagic process. For the experiments described below, we utilized strain
TIGR4. As expected, gene silencing of Atg5 and Atg7, which encode proteins required for canonical autophagy and LAP, abolished both rapamycin (Rapa)-induced autophagic responses (SI
Appendix, Fig. S1 A and B) as well as LC3 colocalization with S.
pneumoniae (Fig. 1 F and G and SI Appendix, Fig. S1 C and D) as
did chemical inhibition with the PI3K inhibitor 3-methyladenine
(3-MA) (Fig. 1H and SI Appendix, Fig. S1E). Similarly, BMDMs
lacking Atg7 exhibited reduced recruitment of GFP-LC3 to S.
pneumoniae, demonstrating that the requirement for ATG7 for
LC3 colocalization with S. pneumoniae in primary cells (Fig. 1I
and SI Appendix, Fig. S1F). Thus, S. pneumoniae infection triggers
a PLY-dependent LC3 recruitment to internalized bacteria in
BMDMs, an autophagic process that requires ATG5, ATG7,
and PI3K.
S. pneumoniae Triggers LAP and Not Canonical Autophagy in Murine
BMDMs. LC3 conversion and recruitment to intracellular com-

partments occurs in both canonical autophagy and nonclassical
processes, such as LAP. LC3 recruitment in canonical autophagy
depends upon initiation and elongation of the phagophore and
can take up to several hours to accomplish, whereas in LAP,
recruitment has been observed as early as 15 min after infection
and can wane after 1 h (40, 41). In our case, we observed a
dramatic increase in LC3 recruitment to S. pneumoniae vesicles
by 0.5-h postinfection that decreased after 1 h (Fig. 1 C and D),
which led us to postulate that LAP rather than canonical autophagy drives LC3 recruitment to S. pneumoniae. To test our
hypothesis, we initially examined the involvement of reactive
oxygen species (ROS) production machinery in S. pneumoniae
triggered LC3 recruitment as PLY induces the production of
intracellular ROS in human neutrophils (51), and generation of
ROS by the NADPH oxidase is often required for LAP (42, 52).
We found that S. pneumoniae and zymosan (Zymo), which induces LAP (52), colocalized with both membrane (NOX2;
gp91phox) and cytosolic (p40phox) components of the NADPH
oxidase (Fig. 2 A and B) and that infection with S. pneumoniae
triggered a significant increase in ROS (Fig. 2C). Pretreatment
Inomata et al.
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Fig. 1. S.p. triggers PLY-dependent LC3 conjugation and colocalization with internalized bacteria. (A) BMDMs treated with BafA1 were infected with indicated strains of S.p. for 1.5 h. Cell lysates were immunoblotted to detect LC3 or as a loading control tubulin. Densitometric quantification of LC3-II was
normalized to tubulin. Data shown are representative of three experiments. (B) RAW264.7 macrophages treated with BafA1 were untreated, starved, or
infected with S.p. at the designated MOI, as indicated, for 1.5 h. Cell lysates were immunoblotted to detect LC3 or tubulin. Densitometric quantification of
LC3-II was normalized to tubulin. Data shown are representative of three experiments (C and D). (C) RAW264.7 macrophages stably expressing GFP-LC3 were
infected with S.p. At 1 h postinfection, cells were stained to identify extracellular and total bacteria as described in Methods. Arrow: intracellular S.p.
colocalized with LC3. (Scale bar, 5 μm.) Shown are representative of three experiments. (D) The percentage of intracellular S.p. that colocalized with LC3 was
quantified at the indicated time points postinfection. Shown are the mean ± SEM of three independent experiments. (E) RAW264.7 macrophages stably
expressing GFP-LC3 were infected with WT, pneumolysin-deficient (Δply) or a revertant with restored ply (“ply revert”) S.p. strains for 1 h. Arrows: intracellular S.p. colocalized with LC3; arrowheads: intracellular S.p. not colocalized with LC3. (Scale bar, 5 μm.) Shown are representative of three experiments.
The percentages of LC3+ S.p. was quantified. Shown are the mean ± SEM of three independent experiments. *P < 0.05 by two-way ANOVA followed by the
Bonferroni test. (F and G) RAW264.7 macrophages stably expressing GFP-LC3 were transfected with siRNA for the control, Atg5 (F), or Atg7 (G) for 48 h. Cell
lysates were immunoblotted to detect Atg5, Atg7, or tubulin, with image representative of three independent experiments. Cells were infected with S.p. for 1
h, and the percentages of LC3+ S.p. were quantified. Shown are the mean ± SEM of three independent experiments. * indicates P < 0.05 by Student’s t test. (H)
RAW264.7 macrophages stably expressing GFP-LC3 were untreated or pretreated with 3-MA for 0.5 h and then infected with S.p. for 1 h. The percentages of
LC3+ S.p. were quantified. Shown are the mean ± SEM of three independent experiments. * indicates P < 0.05 by Student’s t test. (I) BMDMs isolated from
Atg7-knockout (KO) (Atg7flox/flox-LysM-Cre+) or control (Atg7flox/flox-LysM-Cre−) mice were transfected with GFP-LC3 and then were infected with S.p. for 1 h.
The percentage of LC3+ S.p. was quantified. Data show mean ± SEM from one representative experiment from, at least, two independent experiments. *, P <
0.05 by the Mann–Whitney U test. n.s., not significant; S.p., Streptococcus pneumoniae.

of RAW264.7 cells with the NADPH oxidase inhibitor diphenyleneiodonium (DPI) significantly reduced LC3 recruitment to
both Zymo and S. pneumoniae (Fig. 2D). Although PLY was
required for the conversion of LC3-I to LC3-II (Fig. 1A) and for
colocalization of LC3 with internalized S. pneumoniae, PLY is
not required for ROS production (53). Here, we confirmed this
result (SI Appendix, Fig. S2A) and further showed that PLY was
also not required for bacterial colocalization with NOX2
(gp91phox; SI Appendix, Fig. S2B), suggesting that S. pneumoniae
may also trigger ROS production by mechanisms not related to
phagosomal damage.
Next, we characterized the roles of several proteins that are
differentially required for canonical autophagy and LAP for their
involvement in LC3 recruitment to intracellular S. pneumoniae in
Inomata et al.

BMDMs and RAW264.7 macrophages. First, in contrast to LAP,
canonical autophagy requires inactivation of the mTOR pathway
and results in dephosphorylation of the mTOR substrate p70S6K
(54). Indeed, p70S6K was dephosphorylated in BMDMs treated
with Rapa, a known inducer of canonical autophagy but not with
exposure to Zymo or S. pneumoniae (Fig. 3A). In RAW264.7
cells, silencing of Ulk1, FIP200, and Atg14, all of which are required for canonical autophagy but not LAP, eliminated Rapainduced autophagic responses as predicted (SI Appendix, Fig.
S3 A and B) but did not affect LC3 colocalization with S.
pneumoniae (Fig. 3 B–D and SI Appendix, Fig. S3 C–E). In
contrast, silencing Rubicon, which is specifically required for
LAP (52, 55, 56), did not impact Rapa-induced autophagy (SI
Appendix, Fig. S3 A and B) but inhibited LC3 colocalization to S.
PNAS | December 29, 2020 | vol. 117 | no. 52 | 33563

Fig. 2. S.p. triggers an increase in ROS production upon BMDM infection. (A and B) BMDMs were incubated with S.p. or Zymo for 1 h and subjected to
immunofluorescence microscopy. Arrows indicate S.p. or Zymo colocalized with p40phox (A) or NOX2 (gp91phox) (B). (Scale bar, 5 μm.) The percentage of S.p. or
Zymo that colocalized with p40phox (A) or NOX2 (gp91phox) (B) was quantified. Shown are the mean ± SEM from one representative experiment from, at least,
two independent experiments. (C) BMDMs were treated with S.p. or 10-μg/mL Zymo for 1.5 h. The cells were stained with CellROX reagent. Fluorescense was
read on a microplate reader. Shown are the mean ± SEM from one of three independent experiments. *P < 0.05 (Student’s t test). (D) RAW264.7 macrophages
stably expressing GFP-LC3 pretreated with or without 10-mM DPI were treated with S.p. or Zymo for 1 h. The percentage of LC3+ S.p. or Zymo was quantified.
Shown are the mean ± SEM of three independent experiments. *P < 0.05 by Student’s t test. S.p., Streptococcus pneumoniae.
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pneumoniae (Fig. 3B and SI Appendix, Fig. S3C). Similarly, KO
genes uniquely required for LAP, such as Rubicon and Nox2 (54)
significantly reduced LC3 recruitment to S. pneumoniae, whereas
KO of Atg14, a gene essential for canonical autophagy only (54),
did not (Fig. 3 E and F and SI Appendix, Fig. S3 F and G).
Lastly, in canonical autophagy, the cargo becomes entrapped
inside double-membrane structures termed autophagosomes, whereas
in LAP, the target is engulfed into single-membraned phagosomes
(41). We assessed vesicle membrane structure by transmission
electron microscopy. Whereas vesicles in Rapa-treated BMDMs
exhibited double membranes, only single-membrane structures,
indicative of LAP phagosomes, were found to contain Zymo and
S. pneumoniae in BMDMs treated with the respective stimuli
(Fig. 3G and SI Appendix, Table S1). Together, these results
suggest that S. pneumoniae triggers LAP, not canonical autophagy,
in BMDMs.
LAP Promotes Clearance of S. pneumoniae. LAP can result in delivery of microbes to lysosomes for subsequent degradation (38).
We found that most LC3-positive S. pneumoniae vesicles also
colocalized with lysosome-associated membrane protein 2
(LAMP-2) in BMDMs (Fig. 4A), indicating that this process
often resulted in delivery of the bacteria to late endosomes or
lysosomes. To determine whether LAP was important for killing
internalized S. pneumoniae in BMDMs, we assessed S. pneumoniae survival in BMDMs and found that S. pneumoniae was
killed in a time-dependent manner (Fig. 4B). To determine whether
this killing was mediated by LAP, we evaluated S. pneumoniae
killing in BMDMs lacking Atg14, Atg7, Rubicon, or Nox2. BMDMs
lacking Atg14, which is required specifically for canonical autophagy,
cleared S. pneumoniae as effectively as WT BMDMs (Fig. 4C). In
contrast, those lacking Atg7, Rubicon, or Nox2 were defective in S.
pneumoniae clearance (Fig. 4 D and E). ROS have antibacterial
effects against S. pneumoniae independent of LAP (42, 57).
33564 | www.pnas.org/cgi/doi/10.1073/pnas.2015368117

However, we did not observe additional killing defects in in
Nox2 −/− BMDMs compared to LAP defective Rubicon−/−
BMDMs (Fig. 4E). Although Rubicon−/− BMDMs are somewhat
diminished in ROS production upon challenge with Zymo due to
the role of Rubicon in stabilizing NOX2 NADPH oxidase (52),
these results suggest that the primary mechanism of S. pneumoniae
killing in BMDMs depends on ROS-mediated LAP rather than
the direct bacteriocidal activity of ROS.
S. pneumoniae-Triggered LAP Is Impaired in Aged BMDMs. Autophagic activities tend to decline with age (58). As the elderly
population is especially susceptible for S. pneumoniae infection,
we set out to examine whether BMDMs from young and aged
mice differ in S. pneumoniae-triggered LAP. We transfected
BMDMs isolated from young (2-mo old) and aged (20- to 22-mo
old) with GFP-LC3 and confirmed that young and aged BMDMs
displayed no difference in transfection efficiency or posttransfection
cell viability (SI Appendix, Fig. S4). In addition, although S. pneumoniae has been reported to induce cytotoxicity in BMDMs upon
extended (4-h) infection by an MOI of 100 (59), we confirmed no
LDH release by young or aged BMDMs upon pneumococcal infection at an MOI of 50 for 80 min. Upon S. pneumoniae infection
of GFP-LC3-expressing cells, colocalization was significantly
higher in young BMDMs than aged BMDMs throughout the 3-h
time course (Fig. 5 A and B). Immunoblotting for LC3 revealed a
twofold increase in LC3-II conversion in S. pneumoniae-infected
young BMDMs compared to uninfected control as early as 1.5-h
postinfection, whereas infected aged BMDMs responded with no
significant increase in LC3-II even after 3 h of infection (Fig. 5C).
That both LC3 conversion and recruitment are significantly lower
in aged BMDMs suggests that LAP is more efficiently triggered by
S. pneumoniae infection in young BMDMs compared to aged
BMDMs. This relative defect in S. pneumoniae-triggered LAP was
Inomata et al.
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Fig. 3. S.p. triggers LAP and not canonical autophagy in primary murine BMDMs. (A) BMDMs from WT mice were untreated, infected with S.p., or treated
with 10-μg/mL Zymo or 200-nM Rapa for the indicated periods. Cell lysates were immunoblotted to detect p-p70S6K and tubulin. Data are representative of
three independent experiments. (B–D) RAW264.7 macrophages stably expressing GFP-LC3 were transfected with control siRNA, Ulk1 siRNA, or Rubicon siRNA
(B); control siRNA or FIP200 siRNA (C); control siRNA or Atg14 siRNA (D) for 48 h. These cells were treated with S.p. Cell lysates were immunoblotted to detect
Ulk1, Rubicon, FIP200, Atg14, or tubulin. The percentage of LC3+ S.p. was quantified. *P < 0.05, one-way ANOVA with Dunnett’s test. (E and F) BMDMs
isolated from Atg14-KO (Atg14flox/flox-LysM-Cre+) or control (Atg14flox/flox-LysM-Cre−) mice (E); WT, Rubicon−/−, and Nox2−/− (F) were transfected with GFP-LC3
and then were infected with S.p. for 1 h. The percentage of LC3+ S.p. was quantified. Data shown mean ± SEM from one representative experiment from, at
least, two independent experiments. *, P < 0.05 by the Mann–Whitney U test. n.s.. (G) BMDMs were untreated or infected with S.p. for 40 min or treated with
10-μg/mL Zymo for 40 min or 200-nM Rapa for 6 h and subjected to transmission electron microscopy. Images are representative of three experiments.
Arrowheads indicate single membrane; arrows indicate double membrane. The magnified insets represents the area indicated by the squares. (Black scale bar:
2 μm; white scale bar: 500 nm.) n.s., not significant; S.p., Streptococcus pneumoniae.

not due to a defect in ROS production because young and aged
BMDMs produced equivalent amounts (SI Appendix, Fig. S5).
To determine if the decline in LAP in aged BMDMs compromised the ability of aged BMDMs to kill internalized S. pneumoniae,
we measured killing of S. pneumoniae by BMDMs from young or
aged mice over time. Compared to young BMDMs, aged BMDMs
were consistently less efficient at clearing S. pneumoniae over the
120-min period examined (Fig. 6A). We found that silencing of
Rubicon in young BMDMs resulted in a twofold increase in the
survival of S. pneumoniae, but had no effect on the ability of aged
BMDMs to kill the bacterium (Fig. 6B), suggesting that LAP contributes to pneumococcal killing by young BMDM and that the
relative defect of S. pneumoniae-induced LAP in aged BMDM is
associated with a relative defect in bacterial killing.
LAP is immunomodulatory (39) and aging is associated with
higher basal and induced levels of proinflammatory cytokines
(28). In addition, in response to 24 h of infection by S. pneumoniae,
aged mice produce higher levels of Il6, Tnf, and Il1b messenger
RNA (mRNA) (35). We utilized qRT-PCR to quantitate the level
of induction of these cytokine mRNAs upon a 90-min infection by
S. pneumoniae in young or aged BMDMs that had been subjected
to control small interfering RNA (siRNA) or Rubicon siRNA to
diminish LAP. After infection, control siRNA-treated aged BMDMs
produced higher levels of Il6, Tnf, and Il1b compared to control
siRNA-treated young BMDMs, consistent with inflammaging.
Inomata et al.

In young BMDMs infected with S. pneumoniae, inhibition of LAP
by silencing of Rubicon increased cytokine production to levels
indistinguishable from those of the aged BMDMs, indicating that
LAP as predicted functions to diminish inflammatory cytokine
gene expression. In contrast, LAP inhibition in aged BMDMs had
no effect on the production of Il6, Tnf, or Il1b, consistent with our
previous finding that BMDMs LAP is significantly diminished by
aging (Fig. 7). PLY-deficient S. pneumoniae were found to induce
levels of Il6, Tnf, and Il1b statistically indistinguishable from those
induced by WT bacteria (53), a result we confirmed here (SI
Appendix, Fig. S6), indicating that PLY deficiency may trigger
alternate pathways of cytokine production that are not influenced
by autophagic processes. Nevertheless, our findings with Rubicon
siRNA indicate that the decline in a LAP response triggered by
infection of aged BMDMs with WT S. pneumoniae not only reduced killing of S. pneumoniae, but also increased expression of
genes encoding proinflammatory cytokines.
Discussion
In this study, we investigated the interaction of pneumococcus
with BMDMs, which play a critical role in host defense against S.
pneumoniae disease. We found that, upon infection of either
murine BMDMs or a macrophage line, S. pneumoniae triggered LC3
recruitment in a manner dependent upon the pore-forming toxin
PLY. In cultured epithelial cells and fibroblasts, S. pneumoniae has
PNAS | December 29, 2020 | vol. 117 | no. 52 | 33565
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Fig. 4. LAP contributes to clearance of S.p. by BMDMs. (A) BMDMs transfected with GFP-LC3 were infected with S.p. At 1-h postinfection, cells were
stained for S.p., LC3, and LAMP-2. Shown are images representative of three
independent experiments. Arrows: S.p. colocalized with LC3 and LAMP-2.
(Scale bar, 5 μm.) (B) Survival of S.p. in BMDMs from young WT mice. Data
show the mean ± SEM of a representative experiment from, at least, three
independent experiments. (C–E) The percent S.p. survival was determined
after 1.5-h infection of BMDMs from Atg14-KO (Atg14flox/flox-LysM-Cre+) or
control (Atg14flox/flox-LysM-Cre−) mice (C); Atg7-KO (Atg7flox/flox-LysM-Cre+)
or control (Atg7lox/flox-LysM-Cre−) (D); WT, Rubicon−/−, or Nox2−/− (E). Data
show mean ± SEM from a representative experiment from, at least, two
independent experiments. *, P < 0.05 by the Mann–Whitney U test. n.s., not
significant; S.p., Streptococcus pneumoniae.

been shown to elicit autophagy in a PLY-dependent manner
(44–46). Endosomal membrane disruption is one trigger for autophagy activation (60), and several other bacteria that produce
membrane-damaging toxins, including Shigella flexneri, Salmonella
enterica, Vibrio cholerae, Listeria monocytogenes, and Staphylococus
aureus, induce autophagy (45, 61–64). Group A Streptococcus encodes streptolysin O (SLO), a cholesterol-dependent cytolysin highly
related to PLY, that similarly triggers an autophagic process (65).
Although PLY, unlike SLO (66), lacks a canonical secretion signal, it
is localized to the bacterial surface and can also be released upon
bacterial lysis (67–70). In BMDMs, we also found a role for PLY,
but in this case, S. pneumoniae activated LAP. In addition, autophagy and autophagy-related processes can be activated by cell
surface and endosomal pattern recognition receptors, such as Tolllike receptors (TLRs) (41, 71), and PLY (72) as well as other
pneumococcal factors (6) have been reported to interact with TLR2
and TLR4. PLY binds to macrophages and dendritic cell mannose
receptor C type I (73), a phagocytic receptor that is implicated in
enhancing a number of macrophage antimicrobial functions, including autophagy (74). Whether PLY engagement of pattern recognition receptors contributes to LC3 trafficking pathways will
require further investigation.
Several studies have indicated that in fibroblasts or epithelial
cells, S. pneumoniae triggers a canonical autophagic process that
requires factors, such as FIP200 and Ulk1, that are dispensable
for LAP, and results in the engulfment of the bacterium in double33566 | www.pnas.org/cgi/doi/10.1073/pnas.2015368117

membrane autophagosomes (46, 51). Treatment of mice with
Rapa to induce canonical autophagy results in modest protection
from S. pneumoniae lung challenge but is not associated with reduced lung burden (75). We found that S. pneumoniae internalized into BMDMs colocalize with LC3 in a fashion requiring Atg5
and Atg7, two components of the autophagic machinery (48) that
are required for both canonical autophagy and LAP. We developed evidence that in BMDMs, the pathogen triggers LAP rather
than canonical autophagy. p70S6K, a substrate of mammalian target of Rapa (mTOR) and, hence, a protein that is dephosphorylated during metabolically regulated canonical autophagy, remained
phosphorylated in S. pneumoniae-infected BMDMs. Although LC3
recruitment during LAP is reliant on several autophagy proteins,
such as Atg5 and Atg7, it is characterized by its independence from
components of the autophagy preinitiation complex, such as Ulk1,
Atg13, and FIP200 (52), or components of the initiation complex for
canonical autophagy, such as Atg14. We found that depletion of
Ulk1 or FIP200, or depletion or genetic ablation of Atg14, had no
effect on LC3 recruitment to S. pneumoniae, whereas depletion
and/or ablation of autophagic components specific to LAP, such as
Rubicon or Nox2, diminished LC3 recruitment more than twofold.
Reflecting a functional role of the NADPH oxidase, S. pneumoniaeinfected BMDMs generated ROS, a necessary step for LAP but not
canonical autophagy, and chemical inhibition of ROS production
blocked recruitment of LC3 to pneumococcus-containing phagosomes. Finally, internalized S. pneumoniae were sequestered
within single- rather than double-membrane structures, consistent
with LAP. Thus, pharmacological inhibition, genetic silencing and
ablation, and morphological analyses indicate that S. pneumoniae
trigger LAP in BMDMs.
A common method of assessing autophagy, particularly, before
the widespread recognition of LAP as an important means of antimicrobial defense, has been the detection of pathogen-associated
LC3 puncta (36). LC3 localization is associated with both LAP and

Fig. 5. LC3 conjugation and localization to S.p. is impaired in aged BMDMs.
(A) Immunofluorescent (IF) images of LC3 and S.p. at 1-h postinfection in
BMDMs from young and aged mice otransfected with GFP-LC3. Shown are
representative of three experiments. Arrows: intracellular S.p. colocalized with
LC3; arrowheads: intracellular S.p. not colocalized with LC3. (Scale bar, 5 μm.)
(B) The percentage of LC3+ S.p. was quantified. Shown are the mean ± SEM of
three independent experiments. *, P < 0.05 by the Mann–Whitney U test. (C)
BMDMs from young and aged mice were uninfected or infected with S.p. for
the indicated periods. Cell lysates were immunoblotted to detect LC3 or tubulin with image representative of three experiments. Densitometric quantification of LC3-II was normalized to tubulin. Shown are the mean ± SEM of
three independent experiments. *, P < 0.05; n.s. by two-way ANOVA followed
by the Bonferroni test. n.s., not significant; S.p., Streptococcus pneumoniae.
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canonical autophagy, and the emergence of facile methods to
distinguish LAP from canonical autophagy only relatively recently
raised the possibility that LAP occurs in cell types other than
macrophages. For example, high levels of ROS are generated upon
pneumococcal infection of A549 cells, and inhibition of ROS
production decreases autophagy and enhances bacteria survival
(51). In addition, in mouse embryo fibroblasts (MEFs), S. pneumoniae triggers canonical autophagy only after initially activating a
process that resembles LAP in its independence of FIP200 and
Ulk1 (47). However, this early LC3 trafficking in MEFs requires
neither PI3 kinase activity nor ROS production, hallmarks of
conventional LAP (48, 52). Furthermore, in contrast to the bacteriocidal process described here in BMDM (Fig. 4), MEFmediated bacterial killing required further processing to autophagosomes by components of the canonical autophagic machinery,
such as ATG14 (47). The relationship of the noncanonical autophagy pathway in MEFs to LAP in BMDMs described here and
the mechanisms resulting in the disparate fates of internalized
bacteria remain to be explored. The specialized phagocytic nature
of macrophages, for example, in higher levels of NOX2 compared
to fibroblasts (76), the degree of phagosomal acidification, or the
production of serine proteases (77) or antimicrobial peptides (78)
may result in their alternate autophagic responses and subsequent
bacteriocidal efficacy (38).
Recruitment of inflammatory cells, including macrophages, to
the lungs during S. pneumoniae infection is increased in aged
compared to young mice (79) and is associated with greater bacterial burden, raising the possibility that aged macrophages may be
compromised in both effector and immunomodulatory function.
Autophagic capacity declines with age, contributing to many of the
diseases associated with advanced age (58). A number of common
age-related cellular senescence pathways, such as those that increase mitochondrial or endoplasmic reticulum stress, not only
regulate autophagic processes by a myriad of mechanisms (80–82),
but also have been shown to functionally impair macrophage responses to S. pneumoniae (35, 79, 83). Aging is associated with
diminished expression of several autophagy proteins, including
Inomata et al.

Materials and Methods
Reagents. Rapa, 3-MA, DPI, and digitonin were obtained from Millipore
Sigma.

Fig. 7. S.p. cytokine responses are enhanced by inhibition of LAP in young but
not aged BMDMs. siRNA-transfected BMDMs were infected with S.p. for 1.5 h.
RNA was extracted and the levels of cytokines relative to young uninfected
BMDM transfected with control siRNA were determined by qRT-PCR. Shown are
the mean ± SEM of one of three independent experiments. *P < 0.05 by twoway ANOVA followed by the Bonferroni test. S.p., Streptococcus pneumoniae.
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Fig. 6. S.p. survival is enhanced by inhibition of LAP in young but not aged
BMDMs. (A) Survival of S.p. in young and aged BMDMs. Data show the mean ±
SEM of one representative experiment from, at least, three independent experiments. *P < 0.05 by the Mann–Whitney U test. (B) BMDMs from young and
aged mice were transfected with control siRNA or Rubicon siRNA for 48 h. Cell
lysates were immunoblotted to detect Rubicon or tubulin with image representative of three experiments. These cells were infected with S.p. for 1.5 h.
The percent survival after 1.5-h infection compared to 0 min was calculated.
Data show the mean ± SEM of one representative experiment from three
independent experiments. *P < 0.05 by two-way ANOVA followed by the
Bonferroni test. n.s., not significant; S.p., Streptococcus pneumoniae.

those, such as ATG5 and ATG7, that function in both canonical
autophagy and LAP (54). We observed no striking difference in
the level of Rubicon produced by young or aged BMDM
(Fig. 6B); previous studies suggest that age-related differences in
Rubicon expression may differ depending upon tissue type (84,
85). Regardless, in our functional studies, we found that S.
pneumoniae-induced LAP, reflected in the conjugation of LC3
and its colocalization with ingested bacteria, diminished with age.
Bacteriocidal activity was correspondingly compromised in aged
BMDMs, and in contrast to young BMDMs, unaffected by LAP
inhibition. Similarly, aged BMDMs were more highly inflammatory than young BMDMs, reflected in higher levels of proinflammatory cytokine expression after S. pneumoniae infection.
The relatively muted inflammatory response of young compared
to aged BMDMs was due to LAP because LAP inhibition enhanced their response. In contrast, the expression of inflammatory
cytokines after infection of aged (and relatively LAP-deficient)
BMDMs was unaffected by LAP inhibition.
Human monocyte-derived macrophages from frail elderly individuals exhibit a significant defect in controlling S. pneumoniae
(86). The precise nature of this defect remains unclear, but LAPmediated defense has been demonstrated to be critical to host
defense against a variety of infectious agents, several of which cause
more serious infection in aged individuals. For example, adults older
than 65 y are at increased risk of serious food-borne illness caused by
L. monocytogenes or S. enterica (87), two pathogens for which LAP
functions to mitigate systemic infection (88–90). Moreover, the
regulatory effect of LAP on production of proinflammatory cytokines would be predicted to modulate intestinal proliferation of S.
enterica for which growth is metabolically promoted by a robust
inflammatory response (91). Among other lung pathogens, Legionella pnemophila and Mycobacterium tuberculosis cause more severe
illness in the aged (92, 93) and are capable of triggering LAP (94).
Several of the above pathogens are capable of manipulating LAP or
LAP-like pathways (61, 62, 95–97), a property that may render elderly individuals, who may have a preexisting partial defect in LAP,
particularly, susceptible to these infections. Thus, our finding that
LAP is an important innate immune defense employed by BMDMs
to control both S. pneumoniae infection and concomitant inflammation, one that diminishes with age, may provide insight into to the
age-related susceptibility to diverse microbial pathogens.

Bacterial Strains and Mutants. S. pneumoniae TIGR4 (serotype 4) was used as
a WT strain in this study. The TIGR4 mutant strains, including Δcps, Δply,
ΔpspA, and ΔpspC were provided by Professor A. Camilli (Tufts University,
Boston, MA). The S. pneumoniae D39 (serotype 2), D39 mutant strain that
lacks PLY (D39Δply), and D39Δply complemented with PLY (D39Δply ply
comp) were described previously (24). These S. pneumoniae strains were
grown as described in the SI Appendix, SI Materials and Methods.
Mice. Young (2-mo) and aged (22–26-mo) male C57BL/6 mice were purchased
from Charles River Laboratories and the National Institute on Aging rodent
facility. Atg7flox/flox-LysM-Cre and Atg14flox/flox-LysM-Cre were generously
provided by H. W. Virgin (Washington University School of Medicine
[WUSM]). Rubicon−/− mice were provided by D. Young (St. Jude Children’s
Research Hospital, Memphis, TN). Nox2-KO mice were provided by M.
Dinauer (WUSM). All mice were maintained in a specific-pathogen free facility at Tufts University, Gifu University, and Washington University, and all
procedures were performed in accordance with Institutional Animal Care
and Use Committee guidelines. No animals were used in the study if they
had evidence of visible skin lesions, weight loss, or lymphadenopathy.
BMDMs and Mouse RAW264.7 Cells. The phenotype of BMDM induced to
differentiate with granulocyte-macrophage colony-stimulating factor
(GM-CSF) resembles that of macrophages recruited to lungs (98), and we
harvested bone-marrow cells from the femurs and tibiae of male C57BL/6
mice, followed by incubation in differentiation medium, i.e., basal medium
with GM-CSF. BMDMs and RAW264.7 cells (American Type Culture Collection) were grown as described in the SI Appendix, SI Materials and Methods.
Plasmids, siRNA, and Transfection. pGFP-LC3 was a gift from T. Yoshimori
(Addgene plasmid no. 21073) (99). Stealth predesigned siRNAs and the
control nontargeting siRNA (negative control med GC) were acquired from
Thermo Fisher Scientific. Transfection was performed as described in the SI
Appendix, SI Materials and Methods.

Immunofluorescence. Cells (2 × 105 cells/well) were seeded on 4- or 8-well
Permanox slides (Nunc Lab-Tek Chamber Slide System; Thermo Fisher Scientific). The following day, they were infected with S. pneumoniae at an
MOI of 20 for 1 h, washed with phosphate-buffered saline (PBS) three times,
and fixed with 4% paraformaldehyde in PBS for 10 min at 37 °C. To distinguish between intracellular and extracellular S. pneumoniae, extracellular
and total bacteria were differentially stained as described previously (100).
Immunostaining and image acquisition were performed as described in the
SI Appendix, SI Materials and Methods.
Detection of ROS. CellROX reagents for oxidative stress detection (C10448;
Thermo Fisher Scientific) was performed according to the protocol.
RNA Isolation and qRT-PCR. RNA isolation and qRT-PCR were performed as
described in the SI Appendix, SI Materials and Methods.
Statistics. Data are shown as the mean ± SEM. For single comparisons, P
values were calculated using the Mann–Whitney U test or Student’s t test.
For multiple comparisons, two-way ANOVA followed by a Bonferroni test or
one-way ANOVA with Dunnett’s test were used. Differences with P < 0.05
were considered significant.
Data Availability. All study data are included in the article and supporting
information.

Bacterial Killing Assay. To measure BMDM killing of S. pneumoniae, 5 × 105
BMDMs were preincubated with an MOI of 10 bacteria per BMDM for 1 h at
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